1-6 of 6
half-life
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Population pharmacokinetics of the von Willebrand factor–factor VIII interaction in patients with von Willebrand disease

Laura H. Bukkems, Jessica M. Heijdra, Nico C. B. de Jager, Hendrika C. A. M. Hazendonk, Karin Fijnvandraat, Karina Meijer, Jeroen C. J. Eikenboom, Britta A. P. Laros-van Gorkom, Frank W. G. Leebeek, Marjon H. Cnossen, Ron A. A. Mathôt
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1513–1522.
https://doi.org/10.1182/bloodadvances.2020003891
Published: 2021
Includes: Supplemental data
Journal Articles

Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome

Clinical Trials & Observations
Je-Hwan Lee, Stefan Faderl, John M. Pagel, Chul Won Jung, Sung-Soo Yoon, Animesh D. Pardanani, Pamela S. Becker, Howard Lee, Jeongeun Choi, Kyoungjune Lee, Minkyoung Kim, Jorge E. Cortes
Journal: Blood Advances
Blood Adv (2020) 4 (9): 2032–2043.
https://doi.org/10.1182/bloodadvances.2019000757
Published: 2020
Includes: Supplemental data
Journal Articles

FVIII half-life extension by coadministration of a D′D3 albumin fusion protein in mice, rabbits, rats, and monkeys

Sabine Pestel, Hans-Wilhelm Beltz, Philipp Claar, Holger Lind, Marcel Mischnik, Elmar Raquet, Arna Andrews, Jason Simmonds, Vesna Tomasetig, Steven K. Dower, Anna Tjärnlund-Wolf, Stefan Schulte, Peter M. Schmidt, Thomas Weimer
Journal: Blood Advances
Blood Adv (2020) 4 (9): 1870–1880.
https://doi.org/10.1182/bloodadvances.2019000999
Published: 2020
Includes: Supplemental data
Journal Articles

IL-2 enhances ex vivo–expanded regulatory T-cell persistence after adoptive transfer

Scott N. Furlan, Karnail Singh, Christina Lopez, Victor Tkachev, Daniel Joel Hunt, James Hibbard, Kayla M. Betz, Bruce R. Blazar, Cole Trapnell, Leslie S. Kean
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1594–1605.
https://doi.org/10.1182/bloodadvances.2019001248
Published: 2020
Includes: Supplemental data
Journal Articles

Ravulizumab (ALXN1210) in patients with paroxysmal nocturnal hemoglobinuria: results of 2 phase 1b/2 studies

Clinical Trials & Observations
Alexander Röth, Scott T. Rottinghaus, Anita Hill, Eric S. Bachman, Jin Seok Kim, Hubert Schrezenmeier, Louis Terriou, Álvaro Urbano-Ispizua, Richard A. Wells, Jun Ho Jang, Austin G. Kulasekararaj, Jeff Szer, Rasha Aguzzi, Andrew I. Damokosh, Lori Shafner, Jong Wook Lee
Journal: Blood Advances
Blood Adv (2018) 2 (17): 2176–2185.
https://doi.org/10.1182/bloodadvances.2018020644
Published: 2018
Includes: Supplemental data
Journal Articles

The common VWF single nucleotide variants c.2365A>G and c.2385T>C modify VWF biosynthesis and clearance

Ahmad H. Mufti, Kenichi Ogiwara, Laura L. Swystun, Jeroen C. J. Eikenboom, Ulrich Budde, Wilma M. Hopman, Christer Halldén, Jenny Goudemand, Ian R. Peake, Anne C. Goodeve, David Lillicrap, Daniel J. Hampshire
Journal: Blood Advances
Blood Adv (2018) 2 (13): 1585–1594.
https://doi.org/10.1182/bloodadvances.2017011643
Published: 2018
Includes: Supplemental data